Soham, United Kingdom

Graeme Langlands

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Graeme Langlands: Innovator in Pharmaceutical Chemistry

Introduction

Graeme Langlands is a notable inventor based in Soham, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on the development of pharmaceutical salts and polymorphs that target factor Xa inhibitors.

Latest Patents

Langlands' latest patents include innovative formulations that provide salts comprising a compound of Formula I and an acid with activity against mammalian factor Xa. These inventions not only enhance the efficacy of the compounds but also outline methods for their production. The repeated emphasis on factor Xa inhibitors highlights the importance of his research in developing new therapeutic options.

Career Highlights

Throughout his career, Graeme Langlands has worked with prominent companies in the pharmaceutical industry, including Millennium Pharmaceuticals Limited and Millennium Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking advancements in drug development.

Collaborations

Langlands has collaborated with notable professionals in the field, including Craig Grant and James P Kanter. These partnerships have likely enriched his research and led to innovative solutions in pharmaceutical chemistry.

Conclusion

Graeme Langlands stands out as a significant figure in the realm of pharmaceutical inventions. His contributions, particularly in the area of factor Xa inhibitors, demonstrate his commitment to advancing medical science. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…